AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Matrix Gla Protein (MGP), a New Drug Target to Modulate Uterine Quiescence and Contractility

Detailed Technology Description: None

Countries: Not Available

Application No.: None

*Abstract: Pretermbirth is a significant public health problem worldwide. In the US alone,~500,000 premature infants are born annually, yet the underlying mechanisms areunclear. Currently, there is no intervention that effectively protects againstpreterm birth or predicts risk for preterm birth. Researchers at NationwideChildren’s Hospital discovered that Matrix Gla Protein (MGP) is associated withuterine quiescence. This novel discoveryrepresents a promising new drug target for preventing or ceasing preterm laborin at-risk mothers.

*Inquiry: Andrew CorrisThe Research Institute at Nationwide Children’s HospitalOffice of Technology Commercialization700 Children’s DriveColumbus, OH 43205T: (614) 355-1604 F: (614) 722-2716Andrew.Corris@nationwidechildrens.org

*IP Issue Date: None

*IP Type: Other Patent

Country/Region: USA

For more information, please click Here